Skip to main content
Top
Published in: International Journal of Hematology 4/2016

01-10-2016 | Images in Hematology

Atypical amyloid deposits

Authors: Iago Farias Jorge, Jacques Kaufman, Carlos Gustavo Hirth

Published in: International Journal of Hematology | Issue 4/2016

Login to get access

Excerpt

A 57-year-old man presented with a 6-month history of fatigue, fever, polyarthralgia, dysphagia, paresthesia of legs and feet with significant weight loss. At physical examination, bilateral endured hyperchromic plaques on periorbital region (Fig. 1) and an atypical enlargement of the tongue with deep excavations on lateral and anterior borders (Fig. 2) were observed. Echocardiogram showed both systolic and diastolic disfunction and an ejection fraction of 37 %. Bone marrow aspirate contained 22 % of monoclonal plasma cells. A bone marrow biopsy was performed, and immunohistochemical studies showed plasma cells positive for lambda light chain and CD138, and negative for kappa (Fig. 3a–c). Congo-red staining of the tongue and periorbital skin (Fig. 4) showed accumulation of salmon coloring in dermis, evidencing amyloid deposition. A diagnosis of lambda light chain multiple myeloma with systemic amyloidosis was established. The patient was enrolled in chemotherapy protocol bortezomib, cyclophosphamide and dexamethasone with important regression of the skin and tongue lesions (Fig. 5).
Metadata
Title
Atypical amyloid deposits
Authors
Iago Farias Jorge
Jacques Kaufman
Carlos Gustavo Hirth
Publication date
01-10-2016
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2016
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2066-3

Other articles of this Issue 4/2016

International Journal of Hematology 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine